Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 12, 2017 - Issue 5
Submit an article Journal homepage
5,460
Views
22
CrossRef citations to date
0
Altmetric
Drug Profile

Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease

Stuart M. SpragueDepartment of Medicine, NorthShore University HealthSystem, Evanston, IL, USACorrespondence[email protected]
View further author information
,
Stephen A. StrugnellRenal Division, OPKO Health, Inc., Miami, FL, USAView further author information
&
Charles W. BishopRenal Division, OPKO Health, Inc., Miami, FL, USAView further author information
Pages 289-301 | Received 10 Apr 2017, Accepted 23 Jun 2017, Published online: 11 Jul 2017

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mario Cozzolino & Markus Ketteler. (2019) Evaluating extended-release calcifediol as a treatment option for chronic kidney disease-mineral and bone disorder (CKD-MBD). Expert Opinion on Pharmacotherapy 20:17, pages 2081-2093.
Read now

Articles from other publishers (21)

John S. Adams, Albert Shieh & Charles W. Bishop. 2024. Feldman and Pike's Vitamin D. Feldman and Pike's Vitamin D 457 474 .
Laszlo OtvosJr.Jr. & John D. Wade. (2023) Big peptide drugs in a small molecule world. Frontiers in Chemistry 11.
Crossref
Angela Yee-Moon Wang, Rengin Elsurer Afsar, Elizabeth J. Sussman-Dabach, Jennifer A. White, Helen MacLaughlin & T. Alp Ikizler. (2023) Vitamin Supplement Use in Patients With CKD: Worth the Pill Burden?. American Journal of Kidney Diseases.
Crossref
Helga Frank. (2023) Vitamin-D-Therapie: Wer braucht Calcifediol?Vitamin D therapy: Who needs calcifediol?. Die Nephrologie 18:5, pages 321-327.
Crossref
V. V. Krivosheev, I. V. Kozlovsky, L. U. Nikitina & A. V. Fedorov. (2023) International experience of drug correction of vitamin D level depending on its initial level in blood serum and the age of the patient (review and mathematical analysis). Sanitarnyj vrač (Sanitary Doctor):8, pages 521-534.
Crossref
V. V. Krivosheev, I. V. Kozlovsky & L. U. Nikitina. (2023) The problem of vitamin D deficiency among the population and the efficacy of drugs in increasing its level. Sanitarnyj vrač (Sanitary Doctor):6, pages 387-397.
Crossref
Markus Ketteler, Jordi Bover & Sandro Mazzaferro. (2023) Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s. Nephrology Dialysis Transplantation 38:6, pages 1397-1404.
Crossref
Vincent Matthias Brandenburg. (2022) Vitamin D und sekundärer Hyperparathyreoidismus (sHPT) bei CKD im Spiegel der Zeit. Dialyse aktuell 26:10, pages 448-452.
Crossref
Michael J. Germain, Subir K. Paul, George Fadda, Varshasb Broumand, Andy Nguyen, November H. McGarvey, Matthew D. Gitlin, Charles W. Bishop, Philipp Csomor, Stephen Strugnell & Akhtar Ashfaq. (2022) Real-world assessment: effectiveness and safety of extended-release calcifediol and other vitamin D therapies for secondary hyperparathyroidism in CKD patients. BMC Nephrology 23:1.
Crossref
Vincent Brandenburg & Markus Ketteler. (2022) Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future. Nutrients 14:15, pages 3009.
Crossref
Joseph P. O'Shea, Caitriona M. O'Driscoll & Brendan T. Griffin. 2022. Oral Drug Delivery for Modified Release Formulations. Oral Drug Delivery for Modified Release Formulations 137 160 .
Mario Cozzolino, Paola Minghetti & Pierluigi Navarra. (2021) Extended-release calcifediol in stage 3–4 chronic kidney disease: a new therapy for the treatment of secondary hyperparathyroidism associated with hypovitaminosis D. Journal of Nephrology 35:3, pages 863-873.
Crossref
Charles W. Bishop, Stephen A. Strugnell, Philipp Csomor, Edelgard Kaiser & Akhtar Ashfaq. (2022) Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism. American Journal of Nephrology 53:6, pages 446-454.
Crossref
Kai HahnMarkus Ketteler. (2021) CKD-MBD und sekundärer Hyperparathyreoidismus (Teil 2). Dialyse aktuell 25:10, pages 410-417.
Crossref
Michael Pazianas & Paul D. Miller. (2021) Osteoporosis and Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Back to Basics. American Journal of Kidney Diseases 78:4, pages 582-589.
Crossref
Markus Ketteler & Patrice Ambühl. (2021) Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease. Journal of Nephrology 34:5, pages 1405-1418.
Crossref
Hirotaka Komaba, Markus Ketteler, John Cunningham & Masafumi Fukagawa. (2021) Old and New Drugs for the Management of Bone Disorders in CKD. Calcified Tissue International 108:4, pages 486-495.
Crossref
George Fadda, Michael J. Germain, Varshasb Broumand, Andy Nguyen, November McGarvey, Matthew Gitlin, Charles W. Bishop & Akhtar Ashfaq. (2021) Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol. American Journal of Nephrology 52:10-11, pages 798-807.
Crossref
Mengfei Guo, Zaiyong Zhang, Zhaoqiang Chen, Qiaoce Ding, Liye Lu, Qi Zhang, Jian-Rong Wang & Xuefeng Mei. (2020) The axial chirality hidden in vitamin D and its application in cocrystal prediction. CrystEngComm 22:18, pages 3095-3099.
Crossref
Sasan Mirfakhraee & Dwight A. Towler. 2020. Principles of Bone Biology. Principles of Bone Biology 623 644 .
Glenville Jones & Martin Kaufmann. (2018) Update on pharmacologically‐relevant vitamin D analogues. British Journal of Clinical Pharmacology 85:6, pages 1095-1102.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.